GLP-1 / Obesity Stocks
6 stocks · Healthcare sector · flow as of Oct 20, 2026 close
GLP-1 / Obesity stocks: what the data says
As of the Oct 20, 2026 close, NextPick's GLP-1 / Obesity basket shows outflow (flow score -46). That is the 18th-weakest money flow of 110 industry baskets tracked. The basket was up 3.9% on the day and up 1.5% over five sessions.
The basket holds 6 GLP-1 / Obesity stocks in the Healthcare sector. The largest by market cap are LLY, NVO and HIMS. The median member is down 6.2% over the past month. Best one-month returns: LLY (+10.3%), HIMS (−0.4%) and NVO (−1.1%). Weakest: GPCR (−37.8%), ALT (−29.7%) and VKTX (−11.3%). On the latest close, 1 member showed inflow and 4 showed outflow.
2 GLP-1 / Obesity companies report earnings in the next 30 days: LLY (Oct 29) and NVO (Nov 4).
GLP-1 / Obesity stocks list
| Stock | Market cap | Close | 1D | 1M | 3M | Money flow |
|---|---|---|---|---|---|---|
| LLY stockEli Lilly and CompanyLLY earnings | $1.12T | $1,284.88 | +3.59% | +10.30% | +10.48% | inflow |
| NVO stockNovo Nordisk A/SNVO earnings | $171.4B | $39.35 | +2.42% | -1.13% | -18.34% | outflow |
| HIMS stockHims & Hers Health, Inc. | $6.5B | $29.24 | +3.87% | -0.37% | -7.70% | neutral |
| VKTX stockViking Therapeutics, Inc. | $3.2B | $26.71 | +6.63% | -11.29% | -28.41% | strong outflow |
| GPCR stockStructure Therapeutics Inc. | $1.5B | $22.88 | +3.95% | -37.84% | -54.61% | strong outflow |
| ALT stockAltimmune, Inc. | $428M | $2.30 | +3.14% | -29.66% | -18.15% | strong outflow |
GLP-1 / Obesity money flow, last 10 sessions
| Session | Flow score | Signal | Basket 1D |
|---|---|---|---|
| Oct 20, 2026 | -46 | outflow | +3.90% |
| Oct 19, 2026 | -62 | strong outflow | +0.53% |
| Oct 16, 2026 | -50 | outflow | -4.14% |
| Oct 15, 2026 | -40 | outflow | +3.91% |
| Oct 14, 2026 | -39 | outflow | -2.37% |
| Oct 13, 2026 | -48 | outflow | -3.91% |
| Oct 12, 2026 | -49 | outflow | -1.61% |
| Oct 9, 2026 | -43 | outflow | +2.47% |
| Oct 8, 2026 | -29 | weak outflow | -2.62% |
| Oct 7, 2026 | -34 | outflow | +0.37% |
Upcoming GLP-1 / Obesity earnings
- LLY earningsOct 29, 2026
- NVO earningsNov 4, 2026
GLP-1 / Obesity stocks: key questions
What are the biggest GLP-1 / Obesity stocks?
By market cap, the largest GLP-1 / Obesity stocks NextPick tracks are Eli Lilly and Company (LLY), Novo Nordisk A/S (NVO), Hims & Hers Health, Inc. (HIMS), Viking Therapeutics, Inc. (VKTX) and Structure Therapeutics Inc. (GPCR).
Is money flowing into GLP-1 / Obesity stocks?
On the Oct 20, 2026 close, money is flowing out: the basket reads outflow with a flow score of -46, up 3.9% on the day.
Which GLP-1 / Obesity stocks performed best this month?
Over the past 21 sessions the leaders are LLY (+10.3%), HIMS (−0.4%) and NVO (−1.1%).
When do GLP-1 / Obesity stocks report earnings?
LLY reports next, on Oct 29, 2026. 2 members report within 30 days.
Baskets and money-flow scores are NextPick's own sector-flow model built from daily price and volume data; they describe past trading and are not investment advice.